skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

100+ Total results for product and free and sample content found

Pink Sheet

US FDA Advisory Committees Could Get Revamp With A Focus On Science Over Emotion

PS2106_emotionsonrocks_2A6FBP5_1200

CDER Director Cavazzoni also wants to loosen conflict of interest rules and improve technology for remote meetings. Given FDA’s approval of Aduhelm, her comments, made in a prerecorded interview for the BIO Digital annual meeting, may raise some eyebrows. Industry is also working on recommendations for the agency on the topic.

View article

Generics Bulletin

Overseas API Manufacturing Identified As Key Vulnerability In US Supply Chain

GB2106_Biden_Harris_2CD06C5_1200

After US President Joe Biden launched a review of the country’s API supply chain, the task force has reported back with key vulnerabilities that contribute to drug shortages and supply risks during a global public health emergency. According to the report, the lack of geographic diversity and dependence on foreign nations and anti-competitive actions by foreign nations are key areas of concern.

View article

Medtech Insight

Netherland’s DEKRA Is Latest Notified Body Designated Under EU IVDR

netherlands_flag_606897284_1200px

With most IVDs needing to be compliant with the EU’s new IVD Regulation by late May 2022, many more testing bodies are urgently needed. The designation process is limping along, but a fifth organization has been named at last.

View article

Citeline

Informa Pharma Intelligence Launches Citeline Study Feasibility to Accelerate Clinical Trial Timelines

Pharma section 1

New platform will employ machine learning to provide clinical trial sponsors with crucial insights to model feasibility scenarios in seconds

Topic Clinical Trials Clinical Trial Optimization

View press release

Scrip

Biogen/Sage’s Zuranolone Data May Not Be Enough For Tough Commercial Landscape

Depression_703104430_1200x675

The drug may have enough efficacy for approval, but data fell short of the benchmark seen as necessary for commercial adoption.

View article

Medtech Insight

StrataGraft Topical Burn Treatment Gets US FDA Approval

PS2101_FDAbuilding_1851631498_1200

The topical treatment is made from human skin cells and can be applied to speed the healing of deep thermal burns.

View article

Citeline Study Feasibility

Minimizing Luck in Study Feasibility

Minimizing Luck in Study Feasibility

This informative whitepaper introduces you to best practices in study feasibility, which laid the groundwork for our new predictive analytic that is launching soon, Citeline Study Feasibility.  Our industry-leading technology will deliver advanced insight to improve your clinical trial decisions, fast-track enrollment and optimize cycle times – all with less effort.

Topic Clinical Trials

View white paper

Scrip

Novavax’s Latecomer COVID-19 Vaccine Impresses With 90% Efficacy Result

NovavaxFlag

Arriving two to three months later than planned, Novavax’s nanoparticle-based vaccine is still a welcome addition to the field, for both rich and poor countries.

View article

Scrip

Quick Listen: Scrip’s Five Must-Know Things

SC2008_FiveMustKnowThings_1200_Final

In this week's podcast edition of Five Must-Know Things: a ground-breaking approval for Alzheimer’s in the US; LAG-3 inhibitors and new Keytruda data generate excitement at ASCO; and clinical progress for another COVID-19 vaccine.

View article
Show More

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.
Contact Customer Services

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now